Biosante Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $12M | 129k | 91.60 |
| 2025-06-30 | $4.5M | 70k | 65.25 |
| 2025-03-31 | $3.1M | 47k | 66.95 |
| 2024-12-31 | $854k | 15k | 55.28 |
| 2024-09-30 | $804k | 14k | 59.66 |
| 2024-06-30 | $429k | 6.7k | 63.68 |
| 2024-03-31 | $1.1M | 15k | 69.13 |
| 2023-12-31 | $465k | 8.4k | 55.14 |
| 2023-09-30 | $541k | 9.3k | 58.06 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management